Yongming Jia

Dr. Yongming Jia

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
YJYongming Jia
Yongming Jia
NWNa Wang
Na Wang
XLXuewei Liu
Xuewei Liu
The amyloid-beta (Aβ) hypothesis that dyshomeostasis between Aβ production and clearance is a very early, key molecular factor in the etiology of Alzheimer’s disease (AD) has been proposed and examined in the AD research field. Scientists have focused on seeking natural products or drugs to influence the dynamic equilibrium of Aβ, targeting production and clearance of Aβ. There is emerging evidence that resveratrol (Res), a naturally occurring polyphenol mainly found in grapes and red wine, acts on AD in numerous in vivo and in vitro models. Res decreases the amyloidogenic cleavage of the amyloid precursor protein (APP), enhances clearance of amyloid beta-peptides, and reduces Aβ aggregation. Moreover, Res also protects neuronal functions through its antioxidant properties. This review discusses the action of Res on Aβ production, clearance and aggregation and multiple potential mechanisms, providing evidence of the useful of Res for AD treatment.

13 October 2015 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
LWLi Wang
Li Wang
CWChangyuan Wang
Changyuan Wang
YJYongming Jia
Yongming Jia
Zhihao LiuZhihao Liu
Zhihao Liu
XSXiaohong Shu
Xiaohong Shu
KLKexin Liu
Kexin Liu

1 September 2016 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
YJYongming Jia
Yongming Jia
Zhihao LiuZhihao Liu
Zhihao Liu
CWChangyuan Wang
Changyuan Wang
QMQiang Meng
Qiang Meng
XHXiaokui Huo
Xiaokui Huo
KLKexin Liu
Kexin Liu

1 August 2016 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
AZAijie Zhang
Aijie Zhang
YJYongming Jia
Yongming Jia
QXQinghan Xu
Qinghan Xu
CWChangyuan Wang
Changyuan Wang
QLQi Liu
Qi Liu
KLKexin Liu
Kexin Liu

1 January 2017 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
XLXuewei Liu
Xuewei Liu
NWNa Wang
Na Wang
YJYongming Jia
Yongming Jia
BZBo Zhang
Bo Zhang
DXDi Xue
Di Xue
SHShu-Ming Huang
Shu-Ming Huang
Kai Xin San is a Chinese herbal formula composed of Radix Ginseng , Poria , Radix Polygalae and Acorus Tatarinowii Rhizome . It has been used in China for many years for treating amnesia. Kai Xin San ameliorates amyloid-β (Aβ)-induced cognitive dysfunction and is neuroprotective in vivo , but its precise mechanism remains unclear. Expression of insulin-degrading enzyme (IDE), which degrades Aβ, is strongly correlated with cognitive function. Here, we injected rats with exogenous Aβ42 (200 μM, 5 μL) into the hippocampus and subsequently administered Kai Xin San (0.54 or 1.08 g/kg/d) intragastrically for 21 consecutive days. Hematoxylin-eosin and Nissl staining revealed that Kai Xin San protected neurons against Aβ-induced damage. Furthermore, enzyme-linked immunosorbent assay, western blot and polymerase chain reaction results showed that Kai Xin San decreased Aβ42 protein levels and increased expression of IDE protein, but not mRNA, in the hippocampus. Our findings reveal that Kai Xin San facilitates hippocampal Aβ degradation and increases IDE expression, which leads, at least in part, to the alleviation of hippocampal neuron injury in rats.

1 November 2015 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
YJYongming Jia
Yongming Jia
Zhihao LiuZhihao Liu
Zhihao Liu
XHXiaokui Huo
Xiaokui Huo
CWChangyuan Wang
Changyuan Wang
QMQiang Meng
Qiang Meng
KLKexin Liu
Kexin Liu